What Is the Optimal Therapy for Patients with H5N1 Influenza?

Human Infection with Highly Pathogenic Avian Influenza A (H5N1) Virus: Review of Clinical Issues

(2009) Timothy M. Uyeki   CLINICAL INFECTIOUS DISEASES

Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2009) Scott A. Harper et al.   CLINICAL INFECTIOUS DISEASES

TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection

(2009) J. R. Aldridge et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pharmacokinetics of High-Dose Oseltamivir in Healthy Volunteers

(2008) Y. Wattanagoon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in Mice

(2008) N. A. Ilyushina et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Nationally Coordinated Laboratory System for Human Avian Influenza A (H5N1) in Thailand: Program Design, Analysis, and Evaluation

(2008) Rungrueng Kitphati et al.   CLINICAL INFECTIOUS DISEASES

De testimonio: on the evidence for decisions about the use of therapeutic interventions

(2008) Michael Rawlins   LANCET

Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series

(2008) I Nyoman Kandun et al.   LANCET

Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China

(2008) Hua Wang et al.   LANCET

Update on Avian Influenza A (H5N1) Virus Infection in Humans

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Characteristics of 26 Human Cases of Highly Pathogenic Avian Influenza A (H5N1) Virus Infection in China

(2008) Hongjie Yu et al.   PLoS One

Oseltamivir Is Adequately Absorbed Following Nasogastric Administration to Adult Patients with Severe H5N1 Influenza

(2008) Walter R. J. Taylor et al.   PLoS One

Influenza A H5N1 Clade 2.3.4 Virus with a Different Antiviral Susceptibility Profile Replaced Clade 1 Virus in Humans in Northern Vietnam

(2008) Mai T. Q. Le et al.   PLoS One

Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

(2008) B.-J. Zheng et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies

(2008) A. K. Kashyap et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Going from evidence to recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal